Differences in immunophenotypes between myasthenia gravis patients with and without thyroid antibodies

Area of Science:

• Immunology
• Neurology

Background:

• Immunophenotypes correlate with therapeutic efficacy in myasthenia gravis (MG).
• The relationship between immunophenotype and thyroid antibody (TAb) status in MG is not well understood.

Purpose of the Study:

• To investigate differences in immunophenotypes between MG patients with and without TAb positivity.
• To inform the development of targeted immunotherapies for distinct MG patient subgroups.

Main Methods:

• Retrospective observational study of 48 acetylcholine receptor antibody (AchR-Ab) positive MG patients.
• Analysis of peripheral lymphocyte subpopulations using flow cytometry.
• Comparison of immunophenotypes between TAb positive and TAb negative groups.

Main Results:

• TAb positive MG patients had a higher prevalence of ocular MG (53.33% vs. 24.24%).
• Elevated percentages of B cells and CD8+CD28+ cells were observed in TAb positive patients.
• Lower acetylcholine receptor antibody titers, T cell percentages, CD3+HLA-DR+ cells, and CD8+ T cells were found in TAb positive patients.

Conclusions:

• Significant differences in immunophenotypes exist between TAb positive and TAb negative MG patients.
• These immunophenotypic variations suggest potentially different responses to immunotherapy.
• Further research is warranted to explore treatment responses in these distinct MG patient groups.